CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 952645573
- Phone
- 9493792875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- 4 Option exercise Chief Executive Officer acquired 18,000 shares (option exercise)
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 4 Gift Secretary gave 10,000 shares (gift)
- 4 Gift Chief Executive Officer gave 15,000 shares (gift)
- 10-K Report Annual Report
- 10-Q Report Quarterly Report
- 8-K Event Unregistered share sale
- 8-K Event Material agreement · Agreement ended
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 4/A Open-market buy Chief Executive Officer bought 7,000 shares at $0.70 ($4,900)
- 4 Open-market buy Chief Executive Officer bought 7,000 shares at $0.70 ($4,900)
- 10-K Report Annual Report
- 10-Q Report Quarterly Report
- 4 Option exercise Director acquired 25,000 shares (option exercise)
- 4 Option exercise Director acquired 25,000 shares (option exercise)
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 19 of 31 · 605 filings